04/24/2020 12:00 AM EDT
Source: American College of Physicians (ACP). Published: 4/24/2020. This learning activity, updated on April 24, 2020, supports physicians as they respond to the evolving outbreak of the novel coronavirus (COVID-19). Participants will learn to counsel patients regarding infection control methods to reduce risk of transmission for viral illnesses, including coronaviruses; identify potential cases of novel coronavirus infection and report patients under investigation; identify specimen handling and infection control procedures for patients who may be infected with SARS-CoV-2; and access guidance for supervised self-monitoring of healthcare workers exposed to COVID-19. (Video or Multimedia)
04/24/2020 12:00 AM EDT
Source: Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services] (HHS ASPR). Published: 4/24/2020. This one-hour, 27-minute webinar from TRACIE (Technical Resources, Assistance Center, and Information Exchange) features speakers who describe how COVID-19 has resulted in asymmetrical hospital utilization, and discuss Medical Operations Coordination Cells (MOCCs), which are are a strategy to optimize patient distribution by augmenting emergency operations centers with clinical experts who synthesize and coordinate healthcare capacity. (Video or Multimedia)
04/24/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/24/2020. Some governments have suggested that the detection of antibodies to the SARS-CoV-2, the virus that causes COVID-19, could serve as the basis for an “immunity passport” or “risk-free certificate” that would enable individuals to travel or to return to work assuming that they are protected against re-infection. This two-page document discusses how at this point in the pandemic, there is not enough evidence about the effectiveness of antibody-mediated immunity to guarantee the accuracy of an “immunity passport” or “risk-free certificate.” (PDF)
04/24/2020 12:00 AM EDT
Source: Occupational Safety and Health Administration [U.S. Department of Labor] (OSHA). Published: 4/24/2020. This memorandum provides interim guidance to Compliance Safety and Health Officers for enforcing the Respiratory Protection Standard with regard to the reuse of filtering facepiece respirators (FFRs) that have been decontaminated through certain methods. It applies in workplaces in which workers need respirators to protect against exposure to infectious agents that could be inhaled into the respiratory system, including during care of patients with suspected or confirmed coronavirus disease 2019 (COVID-19) and other activities that could result in respiratory exposure to SARS-CoV-2 (the virus that causes COVID-19). (Text)
04/24/2020 12:00 AM EDT
Source: Government of Canada. Published: 4/24/2020. This web page provides guidance to manufacturers of serological assays intended for the detection of antibodies to SARS-CoV-2, the virus that causes COVID-19 disease. It outlines recommendations regarding the minimum testing that should be performed for SARS-CoV-2 diagnostics to support an application for an authorization under the Interim Order Respecting the Importation and Sale of Medical Devices for Use in Relation to COVID-19. (Text)
04/24/2020 12:00 AM EDT
Source: Global Camp Coordination and Camp Management Cluster. Published: 4/24/2020. This one-hour, 26-minute webinar discusses first-hand experiences of country programs preparing to respond to a COVID-19 outbreak in urban neighborhoods and informal sites. It explores how activities in Community Resource Centers and associated mobile outreach teams are adapting to the challenges COVID-19 is presenting to these communities. (Video or Multimedia)
04/23/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/23/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the STANDARD M nCoV Real-Time Detection kit, which received an Emergency Use Authorization from the Food and Drug Administration on April 23, 2020. The STANDARD M nCoV Real-Time Detection kit is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
04/23/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/23/2020. This three-page fact sheet informs healthcare providers of the potential benefits and risks associated with use of a critical care lung support device called the Hemolung Respiratory Assist System (RAS). Hemolung therapy is referred to as extracorporeal carbon dioxide removal (ECCO2R), or respiratory dialysis. The FDA has made Hemolung RAS available under an Emergency Use Authorization (EUA) for treatment of lung failure in COVID-19 patients when used as an adjunct to noninvasive or invasive mechanical ventilation to reduce hypercapnia and hypercapnic acidosis, and/or to maintain normalized levels of partial pressure of carbon dioxide (PCO2) and pH, in patients suffering from acute, reversible respiratory failure for whom ventilation of CO2 cannot be adequately, safely, or tolerably achieved. (PDF)
04/23/2020 12:00 AM EDT
Source: Imperial College London. Published: 4/23/2020. This 13-page study used a simple mathematical model to investigate the potential effectiveness of alternative testing strategies for COVID-19 control. Widespread PCR testing in the general population is unlikely to limit transmission more than contact tracing and quarantine based on symptoms alone, but could allow earlier release of contacts from quarantine. (PDF)
04/23/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 4/23/2020. This one-hour webinar provides a legal and ethical framework for executive decision-making, covering mandatory and discretionary actions and the exercise of professional judgment in responding to COVID-19, and strategies to avoid second-guessing and reduce exposure to liability based on hindsight. (Video or Multimedia)
04/23/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/23/2020. This nine-page interim guidance, developed with UNICEF, supplements the infection prevention and control (IPC) documents by summarizing WHO guidance on water, sanitation, and healthcare waste relevant to viruses, including coronaviruses. It is intended for water and sanitation practitioners and providers, and healthcare providers who want to know more about water, sanitation, and hygiene (WASH) risks and practices during the COVID-19 pandemic. (PDF)
04/22/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/22/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the RealStar® SARS-CoV-2 RT-PCR Kit U.S., which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. The RealStar® SARS-CoV-2 RT-PCR Kit U.S. is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
04/22/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/22/2020. This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the oXiris Set device for the reduction of pro-inflammatory mediators, which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. The oXiris Set device is authorized for emergency use to treat patients 18 years of age or older with confirmed COVID-19 admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure in need of blood purification, including use in continuous renal replacement therapy. (PDF)
04/22/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/22/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Philips IntelliVue Patient Monitors MX750 and MX850; Philips IntelliVue 4-Slot Module Rack FMX-4; and Philips IntelliVue Active Displays AD75 and AD85, which received an Emergency Use Authorization from the Food and Drug Administration on April 22, 2020. These devices are authorized for emergency use by healthcare professionals in the hospital environment for the monitoring of patients having or suspected of having COVID-19, to reduce healthcare provider exposure to COVID-19. (PDF)
04/22/2020 12:00 AM EDT
Source: Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]. Published: 4/22/2020. Serology (antibody) tests for the SARS-CoV-2 virus have the potential to inform good public health decision-making during the COVID-19 pandemic. This 38-page report describes potential uses of the tests, areas of uncertainty where additional research is needed, and examples from other countries now beginning to make use of these tests. (PDF)
Infection Prevention and Control for COVID-19: Second Interim Guidance for Acute Healthcare Settings
04/22/2020 12:00 AM EDT
Source: Government of Canada. Published: 4/22/2020. This resource builds on the foundational infection prevention and control guidance for acute healthcare settings and provides guidance specific to the COVID-19 pandemic in acute care settings. Additional clarification is provided on certain issues (e.g., triage and facility entry points, aerosol-generating medical procedures, organizational readiness, and healthcare worker safety and training). (Text)
04/22/2020 12:00 AM EDT
Source: Government of Canada. Published: 4/22/2020. This web page provides planning guidance for the delivery of health care in Canada during the COVID-19 pandemic, which is expected to result in a prolonged period of increased demand on the health care system. The primary audience is the federal/provincial/territorial (FPT) health sector, although the guidance may also be of use to regional and local health authorities, health professional associations, and others involved in the delivery of health care. (Text)
04/21/2020 12:00 AM EDT
Source: United Kingdom Department of Health (DH). Published: 4/21/2020. This web page provides three documents with information on hydrogen cyanide (HCN) for use in responding to chemical incidents. (Text)
04/21/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 4/21/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Allplex™ 2019-nCoV Assay, which received an Emergency Use Authorization from the Food and Drug Administration on April 21, 2020. The Allplex™ 2019-nCoV Assay is authorized for use on respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider. (PDF)
04/21/2020 12:00 AM EDT
Source: Substance Abuse and Mental Health Services Administration (SAMHSA). Published: 4/21/2020. This four-page document discusses how the home may not be safe during the COVID-19 pandemic for many families who experience domestic violence, which may include both intimate partners and children. It recommends taking action to alert victims of abuse that there is help available, and ensuring that healthcare practitioners are screening patients for intimate partner violence and child abuse. (PDF)
04/21/2020 12:00 AM EDT
Source: Henry J. Kaiser Family Foundation. Published: 4/21/2020. This brief explores mental health and substance use in light of the spread of COVID-19, and discusses the implications of social distancing practices and the current financial crisis on mental health, as well as challenges to accessing mental health or substance use services. (Text)
04/16/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/16/2020. This six-page document, prepared with UNICEF, provides answers to questions about immunizations and vaccine-preventable disease surveillance during the COVID-19 pandemic. Preventing a vaccine-preventable disease outbreak not only saves lives but also requires fewer resources than responding to the outbreak, and helps reduce burden on a health system already strained by the COVID-19 pandemic. (PDF)
04/14/2020 12:00 AM EDT
Source: University of New Mexico (UNM). Published: 4/14/2020. This web page provides links to webinars about the COVID-19 pandemic, in collaboration with the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR), National Emerging Special Pathogens Training and Education Center (NETEC), and Project ECHO at the University of New Mexico. Slides and recordings are available for all webinars. (Video or Multimedia)
04/09/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 4/9/2020. This 34-page document provides overarching principles, as well as specific technical guidance, for malaria interventions, including prevention of infection and disease, care and treatment of cases, testing, clinical services, supply chain, and laboratory activities, during this time of the evolving COVID-19 pandemic. (PDF)
04/02/2020 12:00 AM EDT
Source: American Academy of Pediatrics (AAP). Published: 4/2/2020. Based on current limited evidence as of March 30, 2020, this 18-page report provides interim guidance for the management of infants born to mothers with confirmed and suspected COVID-19. A table details SARS-CoV-2 in Pregnant Women and Newborns and Molecular Testing Results. (PDF)
04/01/2020 12:00 AM EDT
Source: World Health Organization, Pan American Health Organization (PAHO). Published: 4/2020. This web page, updated in April 2020, provides links to COVID-19 technical documents for these topics: Biosafety, Clinical Management, Detection and Diagnosis, Disability-Related Information, Emergency Medical Teams-Medical Surge, Essential Medicines, Ethics, Hospital Readiness, Health Workers, Health Services, Healthy Aging, Hospital Readiness, Infection Prevention and Control, Medical Devices, Prehospital Emergency Medical Services Readiness, Requirements and Technical Specifications - Personal Protective Equipment (PPE), Risk Communication, Social Distancing and Travel-Related Measures, and Surveillance. (Text)
04/01/2020 12:00 AM EDT
Source: National Association of Emergency Medical Technicians (NAEMT). Published: 4/2020. This one-hour, 22-minute webinar features speakers who discuss the emergency medical services (EMS) legal and documentation issues raised by the COVID-19 pandemic, including specific items related to clinical assessment, infection control, medical necessity, and patient disposition that providers must document on a patient care record to protect themselves and their agencies, and potential documentation and patient signature alternatives to reduce the risk of cross-contamination of devices. It is presented in conjunction with LEXIPOL, EMS1, and Page, Wolfberg, & Wirth (PWW). (Video or Multimedia)
04/01/2020 12:00 AM EDT
Source: Johns Hopkins University. Published: 4/2020. The READY Initiative, the London School of Hygiene and Tropical Medicine (LSHTM), the Center for Humanitarian Health at Johns Hopkins University, and the Center of Education and Research in Humanitarian Action (CERAH) are hosting this weekly webinar series on COVID-19 and humanitarian settings. (Video or Multimedia)
04/01/2020 12:00 AM EDT
Source: National Center for Farmworker Health (NCFH). Published: 4/2020. This web page provides links to a four-part webinar series titled COVID-19: Resource Sharing and Discussions with the Frontline. As health centers across the country are being impacted by this crisis, there is a need among health center staff to share how service delivery, such as outreach strategies and enabling services, is being adjusted to maintain patient care. (Video or Multimedia)
03/25/2020 12:00 AM EDT
Source: American Public Health Association (APHA). Published: 3/25/2020. Sponsored by the American Public Health Association and the National Academy of Medicine, this webinar series is exploring the state of the science surrounding the outbreak of COVID-19 in the United States and globally, with a focus on the emerging evidence on how to best mitigate its impact. The page will be regularly updated with new webinars. (Video or Multimedia)
03/18/2020 12:00 AM EDT
Source: Mitre. Published: 3/18/2020. This nine-page document was prepared by a team of MITRE and external experts, who drew on available data and their clinical and epidemiological expertise to offer recommended non-pharmaceutical interventions to disrupt COVID's trajectory. It explains why the emergency policies outlined in this brief are essential for the health and economic security of U.S.citizens. (PDF)
03/01/2020 12:00 AM EST
Source: Harvard University, Harvard T.H. Chan School of Public Health. Published: 3/2020. This web page provides links to a series of webinars about the COVID-19 pandemic presented by the Harvard T.H. Chan School of Public Health, partnering with several other organizations. (Video or Multimedia)
.png)
No hay comentarios:
Publicar un comentario